About Shionogi USA

In February 2001, Shionogi USA, Inc. was established as a subsidiary of Shionogi & Co., Ltd., in order to build a stronger international presence for one of the leading global Japanese pharmaceutical companies.

Shionogi USA, Inc. serves as a primary vehicle for Shionogi & Co., Ltd.’s overseas development, bringing innovative compounds originated in Shionogi Research Laboratories to the US and Europe for clinical development. Shionogi USA, Inc.’s current development activities take place independently or in partnership with other pharmaceutical companies (see Shionogi-GlaxoSmithKline JV).